Irisin in metabolic diseases
Stergios A. Pοlyzos(Aristotle University of Thessaloniki), Christos S. Mantzoros(Beth Israel Deaconess Medical Center), Athanasios D. Anastasilakis(Military Hospital), Polyzois Makras(Hellenic Air Force), Јannis Kountouras(Aristotle University of Thessaloniki), Zoe Efstathiadou(Ippokrateio General Hospital of Thessaloniki), Nikolaos Perakakis(Deutsches Diabetes-Zentrum e.V.)
Cited by 258
Related Papers
Role of leptin in the neuroendocrine response to fasting
|Nature|1996|3.1k
Adverse metabolic and cardiovascular consequences of circadian misalignment
|Proceedings of the National Academy of Sciences|2009|2.3k
Obesity and cancer risk: Emerging biological mechanisms and perspectives
|Metabolism|2018|1.6k
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
|Metabolism|2018|1.2k